circRNA basic information
circBase ID: hsa_circ_0002003
Name: -
Synonym: -
Host Gene: -
Genomic location(hg19): chr8:48320422-48353104:+
Genomic location(hg38): chr8:47407860-47440542:+
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma / HCC
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

HCC tissues; matched non-tumor tissues

Cell lines:

HepG2; Hep3B; Huh7; SNU-387; MHCC97H

In vivo animal model:

-

circRNA-disease information
Expression pattern:
UP
Associated gene: DTYMK, DAP3, STMN1
Associated microRNA: hsa-miR-1343-3p
Biological function: promotes cell growth and metastasis
Molecular mechanism: acts as a miRNA sponge for hsa-miR-1343-3p to regulate downstream target genes (DTYMK, DAP3, STMN1) in a ceRNA network
Biological pathway or process:

proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); ceRNA regulation (other)

Detected method:
Q
S
M
Validation methods:

Microarray; RNA-seq; RT-qPCR; Clinical Sample Validation; Transfection; CCK8; Transwell Assay; Wound Healing Assay; FISH / smFISH; Sanger Sequencing; Luciferase Reporter Assay; Bioinformatics Analysis; Survival Analysis; Western Blot

Clinical significance:

potential prognostic biomarker for HCC; targeting hsa_circ_0002003/hsa-miR-1343-3p/STMN1 axis may be a therapeutic strategy

Description:

hsa_circ_0002003 is up-regulated in HCC and promotes proliferation, migration/invasion and metastasis-related phenotypes in liver cancer cells. It mainly localizes to the cytoplasm and acts as a ceRNA by sponging hsa-miR-1343-3p to affect downstream targets including STMN1 (and also DTYMK, DAP3), with the proposed key axis hsa_circ_0002003/hsa-miR-1343-3p/STMN1.

Confidence score:

0.798

Other information
Title:

Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression.

Journal: BMC cancer
Published: 2023
PubMed ID: 37400785
Study type:

combined biological and clinical study

Data availability: GSE78520; GSE94508; GSE97332; GSE76903; GSE14520; TCGA-LIHC (https://xenabrowser.net/)
Code availability: -